Source document or public record
FDA 510(k) K242256 — QIAstat-Dx Meningitis/Encephalitis (ME) Panel
FDA 510(k) index record K242256. Device: QIAstat-Dx Meningitis/Encephalitis (ME) Panel. Applicant as listed: QIAGEN GmbH. Decision date: 2024-10-29.
Source
"device_name": "QIAstat-Dx Meningitis/Encephalitis (ME) Panel"
This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.
Review and references
Automated FDA record verification
2026-10-20
2026-10-20
professional use
FDA 510(k) public index record K242256.
Device name: QIAstat-Dx Meningitis/Encephalitis (ME) Panel. Applicant as listed: QIAGEN GmbH.
Decision date: 2024-10-29. Decision wording: Substantially Equivalent.
Product code: PLO. Regulation: 21 CFR 866.3970. Medical specialty: Microbiology.
This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.
Interested in these solutions?
Submit a sourcing request with the assays, volumes, and timeline of your own project.